DeFinium Therapeutics Inc (DFTX)
DeFinium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 24,458 | 22,204 | 22,204 | 21,616 | 29,184 |
| Operating Income | -24,458 | -22,204 | -22,204 | -21,616 | -29,184 |
| Interest Expense | 466 | 434 | 439 | 328 | 77 |
| Other Income | 19,070 | -31,762 | -1,221 | 4,021 | 131 |
| Pre-tax Income | -5,854 | -54,400 | -23,864 | -17,923 | -29,130 |
| Net Income Continuous | -5,854 | -54,400 | -23,864 | -17,923 | -29,130 |
| Net Income | $-5,854 | $-54,400 | $-23,864 | $-17,923 | $-29,130 |
| EPS Basic Total Ops | -0.08 | -1.14 | -0.58 | -0.45 | -0.76 |
| EPS Basic Continuous Ops | -0.08 | -1.14 | -0.59 | -0.45 | -0.76 |
| EPS Diluted Total Ops | -0.26 | -1.14 | -0.58 | -0.45 | -0.76 |
| EPS Diluted Continuous Ops | -0.08 | -1.14 | -0.59 | -0.45 | -0.76 |
| EBITDA(a) | $-24,458 | $-21,677 | $-21,313 | $-20,825 | $-28,394 |